Shenyang Tonglian Medicines

Shenyang Tonglian Group is a prominent Chinese pharmaceutical conglomerate specializing in the production of antibiotics and active pharmaceutical ingredients (APIs). Established in 1994, the company has grown into one of the world's largest manufacturing bases for erythromycin and its derivatives, such as azithromycin and clarithromycin. The group operates an integrated business model encompassing research and development, large-scale fermentation, and chemical synthesis across multiple production facilities in Shenyang and Inner Mongolia. In addition to its leadership in the anti-infective market, Tonglian produces a diverse portfolio of cardiovascular, cerebrovascular, and digestive system medications. The company is a key supplier to both the domestic Chinese healthcare system and international pharmaceutical markets, maintaining rigorous GMP standards for its global exports.